Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The latest comprehensive research on the US Syringes & Needles Market has been published, offering a crucial analysis of market dynamics, size forecasts through 2028, and a breakdown of vital sub-segments. The study delivers a deep dive into current trends, growth enablers, and barriers impacting the industry, fostering informed decision-making for stakeholders and participants.
This meticulous report casts light on the US syringes and needles sector, which charted a market valuation of $7.82 billion in 2022. An upward trajectory is expected, with projections estimating the market to soar to $10.87 billion by 2028, growing at a compound annual growth rate (CAGR) of 5.63%. This expansion is attributed to several drivers, including an aging population, a rise in chronic health conditions, amplified efforts in vaccination and immunization, alongside the growing need for diabetes management solutions.
In the segmentation analysis, disposable syringes, a core product type, are seeing significant growth and are anticipated to experience a CAGR of 5.98%. The adult patient segment is drawing particular attention with a dominant market share, forecasted to increase due to the surging incidence of adult chronic diseases and diabetes.
Hospitals as end-users constitute the pivotal segment within the market, with a stake of 56.95% in 2022—a figure that is projected to ascend further. This is reflective of hospitals' central role in disease management, emergency care, and health interventions, thereby driving a sturdy demand for syringes and needles.
Key industry players including BD, ICU Medical, Nipro Corporation, Terumo, and Cardinal Health are spearheading innovation and strategic alliances. Efforts for market consolidation through acquisitions and collaborations with emergent companies are noted, securing their positions and broadening their product offerings in this competitive landscape.
The report is a critical asset for stakeholders, healthcare providers, manufacturers of medical devices, and investors, offering an informative lens through which to view the market's trajectory, opportunities, and competitive environment. It underscores the pertinent trends and growth strategies that are shaping the US syringes & needles sector.
For those engaged in the healthcare apparatus landscape, this latest analysis profiles not just leading companies but also other prominent entities that are enhancing the robustness and reach of this market. With strategic facts and figures, the report stands as a beacon guiding towards informed market strategies and investment decisions.
- Detailed Market Dynamics: Understanding the comprehensive factors that are driving growth in the US syringes & needles industry.
- Segmentation Analysis: Insight into the product, patient, and end-user segments that are defining the current market and its future trajectory.
- Growth Forecast: A projection of the market's growth rate, reflecting the potential that lies within the US for medical devices focused on syringes & needles.
- Competitive Landscape: Analysis of key players and their strategies that are pivotal in shaping the market presence.
As the US healthcare sector continues to evolve, the report promises to serve as an essential tool for navigating the complexities of the syringes & needles market. Its focused insights are tailored to enhance understanding and support strategic planning from 2023 to 2028.
Key Topics Covered:
- Syringes & Needles Market Overview
- Executive Summary
- Key Findings
- Syringes & Needles Market Analysis
- Projected Revenue in the US (2022-2028; $Billions)
- Syringes & Needles Market Segmentation
- Revenue by Product Type
- Syringes: General and Specialized
- Needles: Conventional and Safety
- Revenue by Patient Group: Adults and Pediatrics
- Revenue by End-users: Hospitals, Clinics, Home Healthcare Settings, Others
- Revenue by Product Type
- Syringes & Needles Market Prospects & Opportunities
- Opportunities & Trends
- Market Drivers
- Market Constraints
- Syringes & Needles Industry Overview
- Competitive Landscape
- Key Vendor Profiles
- Other Prominent Vendors
- Key Strategic Recommendations
Key Attributes
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) in 2022 | $7.82 Billion |
| Forecasted Market Value (USD) by 2028 | $10.87 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | United States |
A selection of companies mentioned in this report includes
- BD
- ICU Medical
- Nipro Medical
- Terumo
- Cardinal Health
- Advacare
- Allison Medicals
- Argon Medical Devices
- Aspen Surgical
- ATS Life Sciences
- Baxter
- Codon
- Credence Medsystems
- Dali Medical Devices
- DeRoyal
- Exelint
- Gerreisheimer
- HMD
- Medtronic
- International Medsurg
- MHC Medical
- Nemera
- NovoNordisk
- Teleflex
- Rectractable Technologies
For more information about this report visit https://www.researchandmarkets.com/r/dal9ih
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
